Alethia Young - Sep 6, 2023 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
Director
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
Stock symbol
PTCT
Transactions as of
Sep 6, 2023
Transactions value $
-$464,972
Form type
4
Date filed
9/8/2023, 04:02 PM
Previous filing
Jul 19, 2023
Next filing
Oct 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Options Exercise $195K +7K +77.2% $27.85 16.1K Sep 6, 2023 Direct
transaction PTCT Common Stock Sale -$279K -7K -43.57% $39.90 9.07K Sep 6, 2023 Direct
transaction PTCT Common Stock Options Exercise $130K +4.67K +51.46% $27.85 13.7K Sep 6, 2023 Direct
transaction PTCT Common Stock Sale -$186K -4.67K -33.98% $39.79 9.07K Sep 6, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTCT Stock Option (Right to Buy) Options Exercise -$195K -7K -100% $27.85 0 Sep 6, 2023 Common Stock 7K $27.85 Direct F2
transaction PTCT Stock Option (Right to Buy) Options Exercise -$130K -4.67K -38.88% $27.85 7.33K Sep 6, 2023 Common Stock 4.67K $27.85 Direct F3
holding PTCT Stock Option (Right to Buy) 10K Sep 6, 2023 Common Stock 10K $39.42 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $39.77 to $39.88 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F2 Currently exercisable.
F3 This option was granted on June 9, 2022 and vests over thirty-six approximately equal monthly installments, commencing on July 8, 2022
F4 This option was granted on January 5, 2023 and vests over one year in twelve equal monthly installments, commencing on February 5, 2023.